A global view on carbapenem-resistant Acinetobacter baumannii
- PMID: 37882512
- PMCID: PMC10746149
- DOI: 10.1128/mbio.02260-23
A global view on carbapenem-resistant Acinetobacter baumannii
Abstract
Carbapenem-resistant Acinetobacter baumannii are of increasing public health importance, as they are resistant to last-line antibiotics. International clones with well-characterized resistance genes dominate globally; however, locally, other lineages with different properties may be of importance to consider. This study investigated isolates from a broad geographic origin from 114 hospitals in 47 countries and from five world regions ensuring the greatest possible diversity in an organism known for its propensity for clonal epidemic spread and reflecting the current global epidemiology of carbapenem-resistant A. baumannii. In Latin America, a lineage different from other geographic regions circulates, with a different resistance gene profile. This knowledge is important to adjust local infection prevention measures. In a global world with migration and increasing use of antimicrobials, multidrug-resistant bacteria will continue to adapt and challenge our healthcare systems worldwide.
Keywords: Acinetobacter baumannii; carbapenem resistance; carbapenemase; genome analysis; international clone; molecular epidemiology.
Conflict of interest statement
H.S. has received grants or research support from the BMBF, the German Center for Infection Research (DZIF), and Accelerate Diagnostics and has been a consultant for Debiopharm, Eumedica, Gilead, MSD, and Shionogi. All others have no conflicts of interest to declare.
Figures
Comment in
-
Genomic epidemiology of Acinetobacter baumannii goes global.mBio. 2023 Dec 19;14(6):e0252023. doi: 10.1128/mbio.02520-23. Epub 2023 Nov 1. mBio. 2023. PMID: 37909743 Free PMC article.
References
-
- Villar M, Cano ME, Gato E, Garnacho-Montero J, Miguel Cisneros J, Ruíz de Alegría C, Fernández-Cuenca F, Martínez-Martínez L, Vila J, Pascual A, Tomás M, Bou G, Rodríguez-Baño J, GEIHGEMARAREIPI-Ab20101 Group . 2014. Epidemiologic and clinical impact of Acinetobacter baumannii colonization and infection: a reappraisal. Medicine (Baltimore) 93:202-210. doi:10.1097/MD.0000000000000036 - DOI - PMC - PubMed
-
- Tacconelli E, Carrara E, Savoldi A, Harbarth S, Mendelson M, Monnet DL, Pulcini C, Kahlmeter G, Kluytmans J, Carmeli Y, Ouellette M, Outterson K, Patel J, Cavaleri M, Cox EM, Houchens CR, Grayson ML, Hansen P, Singh N, Theuretzbacher U, Magrini N, WHO Pathogens Priority List Working Group . 2018. Discovery, research, and development of new antibiotics: The WHO priority list of antibiotic-resistant bacteria and tuberculosis. Lancet Infect Dis 18:318–327. doi:10.1016/S1473-3099(17)30753-3 - DOI - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
